NexImmune, Inc.
NASDAQ:NEXI
0.205 (USD) • At close December 26, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|---|
| Revenue
| 0 | 0 | 0 | 0 | 0 | 0 |
| Cost of Revenue
| 1.025 | 1.495 | 0.87 | 0.619 | 0.436 | 0.205 |
| Gross Profit
| -1.025 | -1.495 | -0.87 | -0.619 | -0.436 | -0.205 |
| Gross Profit Ratio
| 0 | 0 | 0 | 0 | 0 | 0 |
| Reseach & Development Expenses
| 18.257 | 47.148 | 37.456 | 17.839 | 15.172 | 7.999 |
| General & Administrative Expenses
| 13,000.624 | 15.934 | 15.799 | 10.012 | 5.714 | 5.244 |
| Selling & Marketing Expenses
| -12,990.714 | 0 | 0 | 0 | 0 | 0 |
| SG&A
| 9.91 | 15.934 | 15.799 | 10.012 | 5.714 | 5.244 |
| Other Expenses
| 0 | -0.088 | -0.061 | 0.09 | 0.092 | 0.137 |
| Operating Expenses
| 28.168 | 63.083 | 53.256 | 27.851 | 20.886 | 13.243 |
| Operating Income
| -29.192 | -63.083 | -53.256 | -27.851 | -20.886 | -13.243 |
| Operating Income Ratio
| 0 | 0 | 0 | 0 | 0 | 0 |
| Total Other Income Expenses Net
| -3.152 | 0.577 | 2.354 | -2.015 | 0.339 | 0.409 |
| Income Before Tax
| -32.344 | -62.506 | -50.902 | -29.866 | -20.547 | -12.834 |
| Income Before Tax Ratio
| 0 | 0 | 0 | 0 | 0 | 0 |
| Income Tax Expense
| -0 | -576.69 | 0.844 | 1.773 | -0.247 | 0.409 |
| Net Income
| -32.344 | 514.184 | -51.745 | -31.639 | -20.3 | -12.834 |
| Net Income Ratio
| 0 | 0 | 0 | 0 | 0 | 0 |
| EPS
| -30.82 | 534.29 | -56.67 | -34.76 | -22.53 | -14.25 |
| EPS Diluted
| -30.82 | 534.29 | -56.67 | -34.76 | -22.53 | -14.25 |
| EBITDA
| -28.168 | -61.588 | -52.394 | -27.122 | -20.449 | -13.038 |
| EBITDA Ratio
| 0 | 0 | 0 | 0 | 0 | 0 |